Maria Wik brings 20 years of experience in CMC development, spanning recombinant proteins, monoclonal antibodies, bi-specifics, and other novel antibody formats, mRNA vaccines, as well as cell and gene therapies. She has held leadership roles in process development, manufacturing science and technology (MSAT), and large-scale GMP manufacturing, and now partners with Syner-G clients to design and execute CMC strategies that deliver impactful treatments to patients.

Previously, Maria served as Director of MSAT at AstraZeneca’s Colorado site and as Senior Director of Manufacturing at Avexis/Novartis Gene Therapies, where she led a team of 130 to a successful facility start-up and first GMP batch within 10 months. She began her career at Amgen and holds a Master of Chemical Engineering from the University of Colorado Boulder and a Bachelor of Science from Hogskolan Dalarna in Sweden.